LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)
Assess today's live LivaNova PLC (LIVN) share price, performance and insights using our live NASDAQ: LIVN stock exchange data.
Analyse the historical data and LivaNova PLC share price performance charts on this page. Our technical summary section provides analysis on LivaNova PLC share price buy/sell indicators using real-time data (or discuss the LivaNova PLC (LIVN) stock price today with other investors in the LivaNova PLC NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LIVN share price (ISIN: GB00BYMT0J19) to enhance your trading decisions with our free investment tools and resources.
What Is the LivaNova PLC Share Price Today?
The LivaNova PLC share price today is 64.23.
What Is the Stock Symbol for LivaNova PLC
The stock symbol (or 'ticker') for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and LivaNova PLC share price performance charts on this page. Our technical summary section provides analysis on LivaNova PLC share price buy/sell indicators using real-time data (or discuss the LivaNova PLC (LIVN) stock price today with other investors in the LivaNova PLC NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LIVN share price (ISIN: GB00BYMT0J19) to enhance your trading decisions with our free investment tools and resources.
What Is the LivaNova PLC Share Price Today?
The LivaNova PLC share price today is 64.23.
What Is the Stock Symbol for LivaNova PLC
The stock symbol (or 'ticker') for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
64.23
-0.92(-1.40%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
64.00
65.57
52 wk Range
35.00
71.92
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
64.0065.57
52 wk Range
35.0071.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIVN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
79.18
Upside
+23.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- LivaNova stock hits 52-week high at $71.00
- Investing.com
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova’s aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
LivaNova PLC SWOT Analysis
Innovation Pipeline | Explore LivaNova's product development strategy, focusing on the Essenz heart-lung machine and potential breakthroughs in sleep apnea and depression treatments |
Market Dynamics | Delve into LivaNova's positioning in the cardiopulmonary and neuromodulation segments, examining competitive pressures and expansion opportunities |
Financial Outlook | Analysts project 6-7% organic growth for LivaNova, with potential to exceed this range. Average price target from analysts stands at $56.50 |
Regulatory Landscape | Uncover the impact of regulatory decisions on LivaNova's growth prospects, including FDA submissions and Medicare coverage reconsiderations |
LivaNova PLC Earnings Call Summary for Q4/2025
- LivaNova Q4 2025 EPS of $0.86 beat estimates of $0.81; revenue hit $360.9M vs. $353.23M forecast, marking fifth year of double-digit EPS growth
- Revenue rose 9.5% YoY on constant currency basis; adjusted operating income increased to $64M from $56M in Q4 2024; gross margin held at 68%
- Stock declined 4.66% to $65.83 in pre-market despite earnings beat, reflecting potential investor concerns over market conditions
- FY 2026 guidance projects EPS range of $0.87-$1.04 quarterly; revenue forecast at $1.47B driven by cardiopulmonary and epilepsy segment expansion
- CEO McDonald emphasized innovation strategy with upcoming FDA approvals and launches in sleep apnea and depression markets to fuel growth
Last Updated: 25/02/2026, 14:24
Read Full TranscriptCompare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.5x | −7.1x | −0.4x | |
PEG Ratio | 0.03 | 0.40 | 0.00 | |
Price/Book | 2.9x | 3.1x | 2.6x | |
Price / LTM Sales | 2.5x | 2.6x | 3.2x | |
Upside (Analyst Target) | 22.8% | 47.9% | 46.7% | |
Fair Value Upside | Unlock | 11.6% | 7.6% | Unlock |
Analyst Ratings
8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 79.18
(+23.28% Upside)
Earnings
Latest Release
25/02/2026
EPS / Forecast
0.86 / 0.81
Revenue / Forecast
360.9M / 353.23M
People Also Watch
FAQ
What Is the LivaNova PLC (NASDAQ: LIVN) Share Price Today?
The LivaNova PLC stock price today is 64.23 USD.
What Stock Exchange Does LivaNova PLC (LIVN) Trade On?
LivaNova PLC is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for LivaNova PLC?
The stock symbol (also called a 'ticker') for LivaNova PLC is "LIVN."
What Is the Current LivaNova PLC Market Capitalisation?
As of today, LivaNova PLC (NASDAQ: LIVN) market cap is 3.52B USD.
What Is LivaNova PLC's (LIVN) Earnings Per Share (TTM)?
The LivaNova PLC EPS is currently -4.45 (Trailing Twelve Months).
When Is the Next LivaNova PLC Earnings Date?
LivaNova PLC's next earnings report will be released on 06/05/2026.
Is LIVN a Buy or Sell From a Technical Analyst Perspective?
Based on today's LivaNova PLC moving averages and other technical indicators, the daily buy/sell signal for LIVN stock is Neutral.
How Many Times Has LivaNova PLC Stock Split?
LivaNova PLC has split 0 times. (See the LIVN stock split history page for full effective split date and price information.)
How Many Employees Does LivaNova PLC Have?
LivaNova PLC has 3300 employees, based on their latest Companies House report.
What is the current trading status of LivaNova PLC (NASDAQ: LIVN)?
As of 24/04/2026, LivaNova PLC (LIVN) is trading at a share price of 64.23 USD, with a previous close of 65.15 USD. The stock has fluctuated within a day range of 64.00 USD to 65.57 USD, while its 52-week range spans from 35.00 USD to 71.92 USD.
What Is LivaNova PLC (LIVN) Price Target According to Analysts?
The average 12-month price target for LivaNova PLC is 79.18 USD, with a high estimate of 90 USD and a low estimate of 67 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +23.28% Upside potential.
What Is the LIVN Premarket Price?
LIVN's last pre-market stock price is 65.40 USD. The pre-market share volume is 40.00, and the stock has decreased by 0.25, or 0.38%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.